多个账号被处置！“心血管XXX主任”“护帮X学长”“药圈XX”等，涉嫌制造焦虑、煽动情绪，误导公众

Core Viewpoint - The central government is actively addressing the spread of false information related to centralized drug procurement, aiming to protect public interest and maintain the integrity of the procurement policy [2]. Group 1: False Information and Misleading Accounts - Several social media accounts, including those on Xiaohongshu and Douyin, have been identified for fabricating false information about the quality of drugs and medical supplies related to centralized procurement, in order to gain traffic [3]. - Accounts on Weibo and Douyin have distorted national policies by spreading false claims such as "imported drugs collectively exiting China," inciting public anxiety regarding original and generic drugs, and promoting specific health products and high-end medical insurance [4]. - Other accounts have deliberately misled the public by associating non-procurement products with procurement, claiming poor quality for items like medical gloves and infusion bags, which are not part of the centralized procurement, thereby undermining public trust in the policy [5]. Group 2: Regulatory Actions and Public Awareness - The central authorities have taken legal actions against the identified accounts to curb the spread of misinformation and protect the integrity of the centralized procurement policy [3][4][5]. - The government agencies are urging the public to approach the centralized drug procurement process with a rational, objective, and scientific mindset, discouraging the spread of rumors and misinformation [5].